These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16873897)

  • 21. Biomarker qualification via public-private partnerships.
    Eck SL; Paul SM
    Clin Pharmacol Ther; 2010 Jan; 87(1):21-3. PubMed ID: 20019697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Futility approaches to interim monitoring by data monitoring committees.
    Demets DL
    Clin Trials; 2006; 3(6):522-9. PubMed ID: 17170036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board.
    Wittes J; Barrett-Connor E; Braunwald E; Chesney M; Cohen HJ; Demets D; Dunn L; Dwyer J; Heaney RP; Vogel V; Walters L; Yusuf S
    Clin Trials; 2007; 4(3):218-34. PubMed ID: 17715247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring clinical trials. Several points are contentious.
    Parry D
    BMJ; 2001 Dec; 323(7326):1425. PubMed ID: 11778590
    [No Abstract]   [Full Text] [Related]  

  • 25. Investigator and site selection and performing GCP clinical studies in India.
    Maggon K
    Control Clin Trials; 2004 Aug; 25(4):366-77. PubMed ID: 15296811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inadequate planning and reporting of adjudication committees in clinical trials: recommendation proposal.
    Dechartres A; Boutron I; Roy C; Ravaud P
    J Clin Epidemiol; 2009 Jul; 62(7):695-702. PubMed ID: 19135860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Professional development of statisticians in the pharmaceutical sector: evolution over the past decade and into the future.
    Lewis T
    Pharm Stat; 2008; 7(3):158-69. PubMed ID: 18720452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials.
    Anderson GL; Kooperberg C; Geller N; Rossouw JE; Pettinger M; Prentice RL
    Clin Trials; 2007; 4(3):207-17. PubMed ID: 17715246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical trial investigator status: you need to earn it.
    Petrelli NJ; Grubbs S; Price K
    J Clin Oncol; 2008 May; 26(15):2440-1. PubMed ID: 18487564
    [No Abstract]   [Full Text] [Related]  

  • 30. Registering clinical trials in India.
    Bhatt A; Sewlikar S
    Natl Med J India; 2006; 19(1):1-3. PubMed ID: 16570676
    [No Abstract]   [Full Text] [Related]  

  • 31. Design of randomized controlled trials.
    Stanley K
    Circulation; 2007 Mar; 115(9):1164-9. PubMed ID: 17339574
    [No Abstract]   [Full Text] [Related]  

  • 32. Rashomon revisited: two views of monitoring the Women's Health Initiative trials.
    Goodman SN
    Clin Trials; 2007; 4(3):205-6. PubMed ID: 17715245
    [No Abstract]   [Full Text] [Related]  

  • 33. Quality management of a large randomized double-blind multi-centre trial: the ACTION experience.
    Kirwan BA; Lubsen J; de Brouwer S; van Dalen FJ; Pocock SJ; Clayton T; Danchin N; Poole-Wilson PA;
    Contemp Clin Trials; 2008 Mar; 29(2):259-69. PubMed ID: 18029294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reflections on early stopping of a clinical trial.
    Armstrong PW; Granger CB
    Am Heart J; 2006 Sep; 152(3):407-9. PubMed ID: 16923403
    [No Abstract]   [Full Text] [Related]  

  • 35. Conduct and reporting of clinical research.
    Liu JL; Altman DG
    Science; 2005 Apr; 308(5719):201-2. PubMed ID: 15821071
    [No Abstract]   [Full Text] [Related]  

  • 36. Monitoring clinical trials. Interim data should not be publicly available.
    Richards SM
    BMJ; 2001 Dec; 323(7326):1424. PubMed ID: 11778588
    [No Abstract]   [Full Text] [Related]  

  • 37. Investigator-Initiated IBD Trials in the United States: Facts, Obstacles, and Answers.
    Herfarth HH; Jackson S; Schliebe BG; Martin C; Ivanova A; Anton K; Sandler RS; Long MD; Isaacs KL; Osterman MT; Sands BE; Higgins PD; Lewis JD
    Inflamm Bowel Dis; 2017 Jan; 23(1):14-22. PubMed ID: 27598744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ethics. Clinical trials guidelines at odds with U.S. policy.
    Normile D
    Science; 2008 Oct; 322(5901):516. PubMed ID: 18948510
    [No Abstract]   [Full Text] [Related]  

  • 39. A primer on the design, conduct, and interpretation of clinical trials.
    Appel LJ
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1360-7. PubMed ID: 17699370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comments on 'maintaining confidentiality of interim data to enhance trial integrity and credibility' by TR Fleming et al.
    Korn EL; Hunsberger S; Freidlin B; Smith MA; Abrams JS
    Clin Trials; 2008; 5(4):364-5; author reply 365-6. PubMed ID: 18697851
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.